Overview

Neural and Antidepressant Effects of Propofol (Phase 2)

Status:
Withdrawn
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Moderate-intensity propofol treatments will be administered to participants who are non-responders at the end of Phase 1.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Utah
Treatments:
Antidepressive Agents
Propofol